4.11 USD
↘ 0.00 (0.02%)PRE MARKET (AS OF 04:02 AM EDT)
Adial Pharmaceuticals, Inc
ADILNASDAQ • USD
Market: OPEN
Adial Pharmaceuticals, Inc (ADIL) trades at $4.11 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (150.6%) and a bullish Golden Cross on the moving averages. On the valuation side, ADIL appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 21, 2026.
Open?$4.06
High?$4.11
Low?$4.06
Prev. Close?$4.11
Volume?N/A
Avg. Volume?40.7K
Bid / Ask
Bid?$2.49 × 100
Ask?$5.88 × 100
Spread?$3.39
Midpoint?$4.19
Valuation & Ratios
Market Cap?10.8M
Shares Out?2.6M
Float?2.4M
Float %?91.9%
P/E Ratio?N/A
P/B Ratio?-0.28
EPS?-$22.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
Address
1180 SEMINOLE TRAIL
CHARLOTTESVILLE, VA 22901
Phone: 434-422-9800
CHARLOTTESVILLE, VA 22901
Phone: 434-422-9800
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?-12.27Distress
Confidence?54%Low
Short InterestElevated
Short % of Float?7.60%Elevated
Short Interest?183.3K
Days to Cover?4.3
Free Float2.4M
Avg Daily Volume42.8K
Settlement Date2026-09-30
Financial Health
Current Ratio?5.63Strong
Quick Ratio?5.63Strong
Cash Ratio?5.61Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-0.28CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.3CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?150.6%STRONG▾
Peers50
S&P97
ROA?-198.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-11132939
Enterprise Value?$-17919592
Fundamentals ratios updated end of day